Open AccessVCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors
Author(s) -
MuQi Wang,
Yaping Li,
Meng Xu,
Ye Tian,
Yuan Wu,
Xin Zhang,
Juanjuan Shi,
Shuangsuo Dang,
Xiaoli Jia
Publication year - 2022
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v14.i10.1933
Subject(s) - hepatocellular carcinoma , immune system , medicine , immune checkpoint , cancer research , cirrhosis , tumor microenvironment , immunotherapy , immunology